Global Coated Stent Graft Market Size By Type (Hemodialysis Access Graft, Endovascular Stent Graft), By Application (Cardiovascular Diseases, Cardiac Aneurysm), By Region, And Segment Forecasts, 2023...

The Global Coated Stent Graft Market was valued at USD 2.4 billion in 2023 and is projected to surpass USD 4.1 billion by 2031, expanding at a CAGR of 6.9% during the forecast period of 2023–2031. Coated stent grafts are widely used in minimally invasive surgeries for treating vascular diseases such as abdominal aortic aneurysms and thoracic aneurysms. The market growth is fueled by rising prevalence of cardiovascular disorders, increasing geriatric population, and advancements in endovascular technologies. Favorable reimbursement policies and a global shift toward less invasive treatments further support market expansion.

Drivers:

Rising Prevalence of Aneurysms and Vascular Diseases

The growing burden of lifestyle-related diseases and increasing incidences of abdominal and thoracic aneurysms have amplified the need for effective vascular treatments, positioning coated stent grafts as critical tools in modern endovascular therapy.

Minimally Invasive Treatment Preference

Healthcare providers and patients alike are increasingly opting for minimally invasive procedures due to faster recovery times and reduced post-operative complications, which continues to drive adoption of coated stent grafts globally.

Technological Advancements in Stent Graft Materials and Coatings

Continuous R&D has resulted in improved biocompatibility, durability, and drug-eluting coatings in stent grafts, enhancing treatment outcomes and propelling innovation in the coated stent graft market.

Restraints:

High Treatment and Device Costs

Despite their clinical advantages, the high costs associated with coated stent grafts and the procedures involved pose a significant barrier, particularly in low-income and developing countries with constrained healthcare budgets.

Stringent Regulatory Requirements

The coated stent graft market faces regulatory challenges, especially related to biocompatibility and long-term safety data, which may delay product approvals and limit innovation cycles.

Opportunity:

Emerging Markets with Underdeveloped Vascular Infrastructure

Countries in Asia-Pacific, Latin America, and parts of Africa offer untapped growth potential, driven by improving healthcare infrastructure, expanding access to vascular interventions, and rising healthcare awareness.

Integration of Drug-Eluting Technology

The development and adoption of drug-eluting coated stent grafts capable of preventing restenosis and improving graft patency present a lucrative growth avenue for manufacturers.

Market by System Type Insights:

The Drug-Eluting Stent Grafts segment dominated the market in 2023 due to its dual functionality—offering both structural support and localized drug delivery. These grafts significantly reduce post-surgical complications such as thrombosis and restenosis. Meanwhile, the Covered Stent Grafts segment continues to witness steady growth, especially in peripheral artery disease treatments, due to their strong mechanical performance and flexibility in complex anatomies.

Market by End-use Insights:

Hospitals held the largest share of the end-use segment in 2023, accounting for over 60% of global revenue. The presence of specialized vascular surgeons, integrated imaging capabilities, and advanced endovascular suites in hospitals drives this segment’s dominance. Ambulatory Surgical Centers (ASCs) are expected to grow rapidly during the forecast period due to the increasing demand for outpatient-based vascular procedures, which are cost-effective and offer shorter hospital stays.

Market by Regional Insights:

North America emerged as the leading regional market in 2023, driven by high awareness, robust reimbursement structures, and advanced healthcare systems. However, Asia-Pacific is anticipated to witness the fastest growth from 2023 to 2031. Rising healthcare investments, increasing incidence of vascular conditions, and a growing elderly population in China and India are key factors fueling regional growth. Europe remains a stable contributor, supported by a high volume of elective vascular procedures.

Competitive Scenario:

Prominent players in the Global Coated Stent Graft Market include Medtronic plc, W. L. Gore & Associates, Cook Medical, Terumo Corporation, Getinge AB, JOTEC GmbH (part of CryoLife), Bentley InnoMed GmbH, Becton Dickinson and Company, B. Braun Melsungen AG, and Boston Scientific Corporation. These companies focus on product innovation, global expansion, and strategic collaborations. For example:

In 2024, Medtronic launched a next-gen drug-eluting stent graft with enhanced deliverability for thoracic aortic repair.

In 2023, Gore announced FDA approval for its novel ePTFE-coated stent graft tailored for complex peripheral interventions.

In 2022, Cook Medical expanded its Zilver portfolio in Europe, introducing a new line of coated stent grafts optimized for challenging anatomies.

Scope of Work – Global Coated Stent Graft Market

Report Metric Details

Market Size (2023) USD 2.4 Billion

Projected Market Size (2031) USD 4.1 Billion

CAGR (2023–2031) 6.9%

Market Segments System Type (Drug-Eluting, Covered), End-Use (Hospitals, ASCs), Region

Growth Drivers Increasing vascular diseases, shift to minimally invasive surgery, stent technology innovation

Opportunities Emerging markets, drug-eluting stent grafts

Key Market Developments:

2024: Boston Scientific began global trials for its new-generation coated stent graft targeting post-implant drug delivery efficiency.

2023: W. L. Gore partnered with a leading hospital network in Europe to roll out its hybrid thoracoabdominal stent graft solution.

2022: Bentley InnoMed received CE Mark approval for BeGraft Plus, a coated balloon-expandable stent graft designed for high-risk arterial lesions.

FAQs:

1) What is the current market size of the Global Coated Stent Graft Market?

The market was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Coated Stent Graft Market?

The primary growth driver is the increasing prevalence of vascular diseases and the growing demand for minimally invasive vascular interventions.

3) Which is the largest region during the forecast period in the Global Coated Stent Graft Market?

North America is the largest region, while Asia-Pacific is expected to register the fastest growth.

4) Which segment accounted for the largest market share in the Global Coated Stent Graft Market?

The Drug-Eluting Stent Grafts segment held the largest market share in 2023.

5) Who are the key market players in the Global Coated Stent Graft Market?

Key players include Medtronic, W. L. Gore, Cook Medical, Terumo Corporation, and Boston Scientific.